The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Characterization and clinical relevance of a new complement-fixing antibod-anti-m8-in patients with primary biliary cirrhosis
Abstract
A new complement-fixing antimitochondrial antibody-anti-M8-was detected in patients with primary biliary cirrhosis. Anti-M8 was only found in association with anti-M2, however, not all anti-M2 positive patients had anti-M8. Thus, among 66 anti-M2 positive patients, 29 were also positive for anti-M8, whereas sera from patients who had the complement-fixing anti-M2 and anti-M4 antibodies in parallel always strongly reacted with the M8 antigen. This group was previously described as mixed form. The M8 antigen was isolated either from human liver mitochondria or pig kidney microsomes and could be clearly distinguished from the M4 antigen. In contrast to M4, M8 was trypsin sensitive and banded at sucrose densities from 1.16 to 1.24, while M4 was found at densities from 1.08 to 1.14. Like M4, the M8 antigen also co-purified with outer mitochondrial membranes. Fifty-three patients with primary biliary cirrhosis have been followed over a period of up to 16 years and were classified according to their complement-fixing antimitochondrial antibody profile. At the time of the first diagnosis, 95% of 31 patients being anti-M2 positive, but anti-M8 negative (antimitochondrial antibody Profile I) were in Stage I or II. In contrast, only 61% of 13 patients being anti-M2 and anti-M8 positive (antimitochondrial antibody Profile II) and 44% of 9 patients with anti-M2, anti-M8 and anti-M4 in parallel (antimitochondrial antibody Profile III) belonged to Stage I or II. At the end of the observation period, only 24% of patients with antimitochondrial antibody Profile I (anti-M8 negative) had reached Stage III or IV, while 75% of patients with antimitochondrial antibody Profile II or III (anti-M8 positive) had a progression to Stage III or IV. It is concluded that the presence of complement-fixing anti-M8 antibody may herald a more progressive course of primary biliary cirrhosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other AMA targets in PBC include sulphite oxidase (AMA-M4)234–236, glycogen phosphorylase (AMA-M9)237 and other unknown mitochondrial antigens (AMA-M8)238.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [238]
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
AN ELECTRON-TRANSPORT SYSTEM ASSOCIATED WITH THE OUTER MEMBRANE OF LIVER MITOCHONDRIA
Sottocasa, G. L., Kuylenstierna, B., Ernster, L., & Bergstrand, A. (1967) · The Journal of Cell Biology · doi:10.1083/jcb.32.2.415 · Cited by 2,317
ENZYMATIC PROPERTIES OF THE INNER AND OUTER MEMBRANES OF RAT LIVER MITOCHONDRIA
Schnaitman, C., & Greenawalt, J. W. (1968) · The Journal of Cell Biology · doi:10.1083/jcb.38.1.158 · Cited by 1,386
Succinate-linked diphosphopyridine nucleotide reduction in submitochondrial particles
Löw, H., & Vallin, I. (1963) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(63)91269-1 · Cited by 495
IMMUNOREACTIVE α-INTERFERON IN INSULIN-SECRETING β CELLS IN TYPE 1 DIABETES MELLITUS
Foulis, A., Farquharson, M., & Meager, A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91128-7 · Cited by 446
Roll, J., Boyer, J. L., Barry, D., & Klatskin, G. (1983) · New England Journal of Medicine · doi:10.1056/nejm198301063080101 · Cited by 417
Serum bilirubin: a prognostic factor in primary biliary cirrhosis
Shapiro, J. M., Smith, H., & Schaffner, F. (1979) · Gut · doi:10.1136/gut.20.2.137 · Cited by 319
Christensen, E., Crowe, J., Doniach, D., Popper, H., Ranek, L., Rodés, J., Tygstrup, N., & Williams, R. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90571-5 · Cited by 273
Microsomal antibodies in active chronic hepatitis and other disorders.
Rizzetto, M., Swana, G. T., & Doniach, D. (1973) · PubMed · Cited by 248
Research works printed but not linked: 11
- Berg, 1969, Clin Exp Immunol, 4, 511
- Meek, 1980, Clin Exp Immunol, 39, 599
- Lindenborn-Fotinos, 1982, Clin Exp Immunol, 50, 267
- Klein, 1984, Clin Exp Immunol, 58, 283
- Sayers, 1979, Clin Exp Immunol, 37, 68
- Labro, 1978, Clin Exp Immunol, 31, 357
- Homberg, 1982, Clin Exp Immunol, 47, 93
- Rizzetto, 1973, Clin Exp Immunol, 15, 331
- , . Glucose-6-phosphatase. In: ed. Meth der Enzymat Analyse. Weinheim/Bergstr.: Verlag Chemie, 1974: 909–913.
- . WHO handbook of immunological techniques. Geneva: World Health Organization, 1979.
- Miyachi, 1980, Clin Exp Immunol, 39, 599
Cited by
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
Van de Water, J., Cooper, A., Surh, C. D., Coppel, R., Danner, D., Ansari, A., Dickson, R., & Gershwin, M. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905253202104 · Cited by 201
Primary biliary cirrhosis and mitochondrial autoantigens—insights from molecular biology
Gershwin, E. M., Coppel, R. L., & Mackay, I. R. (1988) · Hepatology · doi:10.1002/hep.1840080128 · Cited by 100
The role of mitochondria in rheumatic diseases
Becker, Y. L. C., Duvvuri, B., Fortin, P. R., Lood, C., & Boilard, E. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00834-z · Cited by 81
Mitochondrial antigens, molecular mimicry and autoimmune disease
Baum, H. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00017-x · Cited by 67
Metadata
- Authors
- Weber, P., Brenner, J., Stechemesser, E., Klein, R., Weckenmann, U., Klöppel, G., Kirchhof, M., Fintelmann, V., & Berg, P. A.
- Affiliations
- Universität Hamburg (DE)
- Venue
- Hepatology
- Published
- 1986-07
- Volume
- 6
- Issue
- 4
- Pages
- 553-559
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1990590661
- Cited by
- 50
- References
- 33
- Citations by year
- 2025: 1 · 2022: 2
- FWCI
- 8.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 10654 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Dermatology › Autoimmune Bullous Skin Diseases
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Keywords
- primary biliary cirrhosis, antimitochondrial antibodies, anti-M2 antibodies, complement-fixing antibodies, mitochondrial antigens, mitochondrial outer membrane, disease progression, prognosis, antibody profiles
- MeSH terms
- Antibodies, Antibody Specificity, Antigens, Centrifugation, Density Gradient, Chromatography, Gel, Complement System Proteins, Complement Fixation Tests, Electrophoresis, Polyacrylamide Gel, Enzymes, Follow-Up Studies, Immunodiffusion, Humans, Intracellular Membranes, Kidney, Liver Cirrhosis, Biliary, Mitochondria, Liver, Prognosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization and clinical relevance of a new complement-fixing antibod-anti-m8-in patients with primary biliary cirrhosis. https://app.cochat.ai/papers/10.1002/hep.1840060402
- The paper
- Weber, P., Brenner, J., Stechemesser, E., Klein, R., Weckenmann, U., Klöppel, G., Kirchhof, M., Fintelmann, V., & Berg, P. A. (1986). Characterization and clinical relevance of a new complement-fixing antibod-anti-m8-in patients with primary biliary cirrhosis. Hepatology. https://doi.org/10.1002/hep.1840060402
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.